AFYA
AFYA ANNOUNCES
THE ACQUISITION OF RX PRO
THE DIGITAL MULTICHANNEL PLATFORM THAT CONNECTS PHYSICIANS TO THE PHARMACEUTICAL INDUSTRY
OCTOBER 2021
Safe Harbor
This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which statements involve substantial risks and uncertainties. All statements other than statements of historical fact could be deemed forward looking, including risks and uncertainties related to statements about our competition; our ability to attract, upsell and retain students; our ability to increase tuition prices; our ability to anticipate and meet the evolving needs of student and teachers; our ability to source and successfully integrate acquisitions; general market, political, economic, and business conditions, and our financial targets such as revenue, share count and IFRS and non-IFRS financial measures including gross margin, operating margin, net income (loss) per diluted share, and free cash flow. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the potential impacts of the COVID-19 pandemic on our business operations, financial results and financial position and on the Brazilian economy.
The Company undertakes no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as required by law. The achievement or success of the matters covered by such forward-looking statements involves known and unknown risks, uncertainties and assumptions. If any such risks or uncertainties materialize or if any of the assumptions prove incorrect, our results could differ materially from the results expressed or implied by the forward-looking statements we make. Readers should not rely upon forward-looking statements as predictions of future events. Forward-looking statements represent management's beliefs and assumptions only as of the date such statements are made. Further information on these and other factors that could affect the Company's financial results is included in filings made with the United States Securities and Exchange Commission (SEC) from time to time, including the section titled "Risk Factors" in the most recent Rule 434(b) prospectus. These documents are available on the SEC Filings section of the investor relations section of our website at: https://ir.afya.com.br/.
RX PRO: a digital experience with a reliable sample delivery for physicians
RX PRO is a solution that connects physicians with the pharmaceutical industry, providing specialized and personalized marketing for those companies, in a more convenient way for physicians.
RX PRO does this by delivering free samples to a community of pre-selected physicians, using third-party logistics and offering medical updates regarding pharmaceutical products, and treatments in a fast and efficient way for doctors.
SERVICE
COMMUNICATION
DATA
LOGISTICS
• CONNECTION OF
• UPDATES OF NEW DRUGS AND
• BUSINESS INTELLIGENCE: ACCESS
•
SAMPLE DELIVERY USING
PHARMACEUTICAL INDUSTRY
TREATMENTS
TO DATA AND ROI OF THE
THIRD-PARTY LOGISTICS
WITH PHYSICIANS
• WEBINARS / TUTORIALS
PHARMA MARKETING
•
MARKETING MATERIAL
• DIGITAL PLATFORM TO IMPROVE
INVESTMENT
DELIVERY
BRAND EXPERIENCE FOR
PHYSICIANS
RX PRO Experience
MEDICAL DETAILING AT THE TIME AND THE WAY PHYSICIANS WISH,
ACCORDING TO THE MODERN DYNAMICS WITH PATIENTS
RX PRO Overview
46,693
12
83
PHYSICIANS ALREADY RECEIVED
PHARMA COMPANIES USING
NPS
FREE SAMPLES
RX PRO SYSTEM
R$ 8.9 MM
MODEL FOCUSED ON
EXPECTED FY 2021
B2B CONTRACTS
GROSS REVENUE
This is an excerpt of the original content. To continue reading it, access the original document here.
Disclaimer
Afya Ltd. published this content on 01 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 October 2021 20:32:10 UTC.